L1CAM malfunction in the nervous system and human carcinomas

被引:0
|
作者
Michael K. E. Schäfer
Peter Altevogt
机构
[1] University of Freiburg,Center for Neurosciences, Institute of Anatomy and Cell Biology
[2] German Cancer Research Center,D015
来源
关键词
Cell adhesion molecule; Neurological disorders; L1 syndrome; Cancer; Cell migration;
D O I
暂无
中图分类号
学科分类号
摘要
Research over the last 25 years on the cell adhesion molecule L1 has revealed its pivotal role in nervous system function. Mutations of the human L1CAM gene have been shown to cause neurodevelopmental disorders such as X-linked hydrocephalus, spastic paraplegia and mental retardation. Impaired L1 function has been also implicated in the aetiology of fetal alcohol spectrum disorders, defective enteric nervous system development and malformations of the renal system. Importantly, aberrant expression of L1 has emerged as a critical factor in the development of human carcinomas, where it enhances cell proliferation, motility and chemoresistance. This discovery promoted collaborative work between tumour biologists and neurobiologists, which has led to a substantial expansion of the basic knowledge about L1 function and regulation. Here we provide an overview of the pathological conditions caused by L1 malfunction. We further discuss how the available data on gene regulation, molecular interactions and posttranslational processing of L1 may contribute to a better understanding of associated neurological and cancerous diseases.
引用
收藏
页码:2425 / 2437
页数:12
相关论文
共 50 条
  • [1] L1CAM malfunction in the nervous system and human carcinomas
    Schaefer, Michael K. E.
    Altevogt, Peter
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (14) : 2425 - 2437
  • [2] L1CAM in human cancer
    Altevogt, Peter
    Doberstein, Kai
    Fogel, Mina
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (07) : 1565 - 1576
  • [3] L1cam does not interact with Ret during enteric nervous system development
    Wallace, A. S.
    Bergner, A.
    Anderson, R. B.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (02): : XXV - XXV
  • [4] L1cam acts as a modifier gene during enteric nervous system development
    Wallace, Adam S.
    Schmidt, Claudia
    Schachner, Melitta
    Wegner, Michael
    Anderson, Richard B.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (03) : 622 - 633
  • [5] L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
    Louis JM van der Putten
    Nicole CM Visser
    Koen van de Vijver
    Maria Santacana
    Peter Bronsert
    Johan Bulten
    Marc Hirschfeld
    Eva Colas
    Antonio Gil-Moreno
    Angel Garcia
    Gemma Mancebo
    Fransesc Alameda
    Jone Trovik
    Reidun K Kopperud
    Jutta Huvila
    Stefanie Schrauwen
    Martin Koskas
    Francine Walker
    Vit Weinberger
    Lubos Minar
    Eva Jandakova
    Marc PLM Snijders
    Saskia van den Berg-van Erp
    Xavier Matias-Guiu
    Helga B Salvesen
    Frederic Amant
    Leon FAG Massuger
    Johanna MA Pijnenborg
    British Journal of Cancer, 2016, 115 : 716 - 724
  • [6] L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
    van der Putten, Louis J. M.
    Visser, Nicole C. M.
    van de Vijver, Koen
    Santacana, Maria
    Bronsert, Peter
    Bulten, Johan
    Hirschfeld, Marc
    Colas, Eva
    Gil-Moreno, Antonio
    Garcia, Angel
    Mancebo, Gemma
    Alameda, Fransesc
    Trovik, Jone
    Kopperud, Reidun K.
    Huvila, Jutta
    Schrauwen, Stefanie
    Koskas, Martin
    Walker, Francine
    Weinberger, Vit
    Minar, Lubos
    Jandakova, Eva
    Snijders, Marc P. L. M.
    van den Berg-van Erp, Saskia
    Matias-Guiu, Xavier
    Salvesen, Helga B.
    Amant, Frederic
    Massuger, Leon F. A. G.
    Pijnenborg, Johanna M. A.
    BRITISH JOURNAL OF CANCER, 2016, 115 (06) : 716 - 724
  • [7] L1CAM in the Early Enteric and Urogenital System
    Pechriggl, Elisabeth Judith
    Concin, Nicole
    Blumer, Michael J.
    Bitsche, Mario
    Zwierzina, Marit
    Dudas, Jozsef
    Koziel, Katarzyna
    Altevogt, Peter
    Zeimet, Alain-Gustave
    Fritsch, Helga
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2017, 65 (01) : 21 - 32
  • [8] miR-21-3p is a positive regulator of L1CAM in several human carcinomas
    Doberstein, Kai
    Bretz, Niko P.
    Schirmer, Uwe
    Fiegl, Heidi
    Blaheta, Roman
    Breunig, Christian
    Mueller-Holzner, Elisabeth
    Reimer, Dan
    Zeimet, Alain G.
    Altevogt, Peter
    CANCER LETTERS, 2014, 354 (02) : 455 - 466
  • [9] Interactions between L1cam and Sox10 during enteric nervous system development
    Anderson, R. B.
    Wallace, A. S.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (02): : II - II
  • [10] Neuroradiological criteria of human L1CAM syndrome – report of 24 human L1CAM mutations including 17 noble mutations and clinical evaluation
    M Yamasaki
    Y Kanemura
    N Okamoto
    H Sakamoto
    H Kamiguchi
    Cerebrospinal Fluid Research, 1 (Suppl 1):